Radium-223 (Rad) and niraparib (Nira) treatment (tx) in castrate-resistant prostate cancer (CRPC) patients (pts) with and without prior chemotherapy (chemo).

被引：0
|
作者：
Kelly, William Kevin
Leiby, Benjamin
Einstein, David Johnson
Szmulewitz, Russell Zelig
Sartor, A. Oliver
Yang, Eddy Shih-Hsin
Sonpavde, Guru
机构：
[1] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Philadelphia, PA 19107 USA
[2] Thomas Jefferson Univ, Dept Pharmacol & Expt Therapeut, Philadelphia, PA USA
[3] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[4] Univ Chicago, Chicago, IL 60637 USA
[5] Tulane Canc Ctr, New Orleans, LA USA
[6] Univ Alabama Birmingham, Birmingham, AL USA
[7] Dana Farber Canc Inst, Dept Genitourinary Oncol, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5540
引用
收藏
页数：2
相关论文
共 50 条
  • [11] Imaging response during therapy (tx) with radium-223 (Ra-223) for castrate resistant prostate cancer (CRPC) with bone metastases (BM)
    Keizman, Daniel
    Peer, Avivit
    Neumann, Avivit
    Rosenbaum, Eli
    Neiman, Victoria
    Gottfried, Maya
    Kuchuk, Iryna
    Sarid, David
    Gez, Eliahu
    Mermershtain, Wilmosh
    Rouvinov, Keren
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [12] Radium-223 in the treatment of metastatic castrate-resistant prostate cancer: A real-world Irish experience
    Peters, Niamh
    Gaffney, John
    Connolly, Emma
    Bambury, Richard
    Power, Derek Gerard
    Kelly, Paul J.
    Jamaluddin, Muhammad Faisal
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [13] Completion of radium-223 dichloride treatment regimen for patients with castrate resistant prostate cancer
    Amin, Kanak
    Shrikanthan, Sankaran
    Richard, Full
    Neumann, Donald
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [14] Single Center Clinical Experience With Radium-223 Dichloride In Patients With Metastatic Castrate-resistant Prostate Cancer
    Tiskevicius, S.
    Vidrinskaite, A.
    Stalnionis, M.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S572 - S572
  • [15] Parameters Associated With 6 Cycles of Radium-223 Dichloride Therapy in Metastatic Castrate-Resistant Prostate Cancer
    Stolten, M. D.
    Steinberger, A. E.
    Cotogno, P. M.
    Ledet, E. M.
    Lewis, B. E.
    Sartor, O.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E196 - E196
  • [16] Experience with radium-223 as a systemic treatment for patients (pts) with castration-resistant prostate cancer (CRPC) out of a clinical trial in Spain
    Grande, E.
    Pinto, A.
    Duran, I.
    Lopez-Criado, P.
    Suarez, C.
    Gonzalez-Larriba, J. L.
    Sanchez-Lorenzo, L.
    Maroto, P.
    Lainez, N.
    Gonzalez del Alba, A.
    Saez, M. I.
    Alonso-Gordoa, T.
    Perez-Valderrama, B.
    Puente, J.
    Morales, R.
    Esteban, E.
    Manneh, R.
    Benedetti, J.
    Carles-Galceran, J.
    Castellano, D.
    [J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 : S488 - S489
  • [17] A National Multicenter Study on overall survival in elderly metastatic castrate-resistant prostate cancer patients treated with Radium-223
    Frantellizzi, Viviana
    Monari, Fabio
    Mascia, Manlio
    Costa, Renato
    Rubini, Giuseppe
    Spanu, Angela
    Farcomeni, Alessio
    Rizzini, Elisa Lodi
    Cindolo, Luca
    Murabito, Alessandra
    Lavelli, Valentina
    Nuvoli, Susanna
    Cosma, Laura
    Dionisi, Valeria
    Nappi, Anna Giulia
    Andreola, Marco
    De Vincentis, Giuseppe
    [J]. AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2021, 33 (03) : 651 - 658
  • [18] A National Multicenter Study on overall survival in elderly metastatic castrate-resistant prostate cancer patients treated with Radium-223
    Viviana Frantellizzi
    Fabio Monari
    Manlio Mascia
    Renato Costa
    Giuseppe Rubini
    Angela Spanu
    Alessio Farcomeni
    Elisa Lodi Rizzini
    Luca Cindolo
    Alessandra Murabito
    Valentina Lavelli
    Susanna Nuvoli
    Laura Cosma
    Valeria Dionisi
    Anna Giulia Nappi
    Marco Andreola
    Giuseppe De Vincentis
    [J]. Aging Clinical and Experimental Research, 2021, 33 : 651 - 658
  • [19] INFLUENCE OF PALLIATIVE RADIOTHERAPY ON TOXICITY AND SURVIVAL IN PATIENTS TREATED WITH RADIUM-223 DICHLORIDE FOR METASTATIC CASTRATE-RESISTANT PROSTATE CANCER
    Charrois-Durand, Cedric
    Delouya, Guila
    Taussky, Daniel
    Barkati, Maroie
    Saad, Fred
    Lattouf, Jean-Baptiste
    Perrotte, Paul
    Karakiewicz, Pierre
    Soulieres, Denis
    Blais, Normand
    Hamilou, Zineb
    Juneau, Daniel
    Plouznikoff, Nicolas
    [J]. RADIOTHERAPY AND ONCOLOGY, 2022, 174 : S72 - S73
  • [20] One-Year Postapproval Clinical Experience with Radium-223 Dichloride in Patients with Metastatic Castrate-Resistant Prostate Cancer
    Jadvar, Hossein
    Challa, Sudha
    Quinn, David I.
    Conti, Peter S.
    [J]. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2015, 30 (05) : 195 - 199
12345